Quest Diagnostics Aktie
WKN: 904533 / ISIN: US74834L1008
09.04.2025 14:20:38
|
Quest Diagnostics Launches New Blood Test To Confirm Alzheimer's Disease
(RTTNews) - Quest Diagnostics (DGX), Wednesday announced the launch of a new blood test designed to confirm amyloid brain pathology due to Alzheimer's disease (AD) in patients with mild cognitive impairment (MCI) or dementia.
In a presentation at the American Academy of Neurology (AAN), the scientists presented data suggesting the test named AD-Detect can accurately assess Alzheimer's disease pathology with greater than 90% sensitivity and specificity.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Quest Diagnostics Inc.mehr Nachrichten
Analysen zu Quest Diagnostics Inc.mehr Analysen
Aktien in diesem Artikel
Quest Diagnostics Inc. | 142,30 | -0,32% |
|